BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20934429)

  • 1. Modeling major histocompatibility complex binding by nonparametric averaging of multiple predictors and sequence encodings.
    Huang JC; Jojic N
    J Immunol Methods; 2011 Nov; 374(1-2):35-42. PubMed ID: 20934429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ensemble approaches for improving HLA class I-peptide binding prediction.
    Hu X; Mamitsuka H; Zhu S
    J Immunol Methods; 2011 Nov; 374(1-2):47-52. PubMed ID: 20849860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting peptide binding to Major Histocompatibility Complex molecules.
    Liao WW; Arthur JW
    Autoimmun Rev; 2011 Jun; 10(8):469-73. PubMed ID: 21333759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties.
    Tung CW; Ho SY
    Bioinformatics; 2007 Apr; 23(8):942-9. PubMed ID: 17384427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of genetic search in derivation of matrix models of peptide binding to MHC molecules.
    Brusic V; Schönbach C; Takiguchi M; Ciesielski V; Harrison LC
    Proc Int Conf Intell Syst Mol Biol; 1997; 5():75-83. PubMed ID: 9322018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC-NP: predicting peptides naturally processed by the MHC.
    Giguère S; Drouin A; Lacoste A; Marchand M; Corbeil J; Laviolette F
    J Immunol Methods; 2013 Dec; 400-401():30-6. PubMed ID: 24144535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two complementary methods for predicting peptides binding major histocompatibility complex molecules.
    Gulukota K; Sidney J; Sette A; DeLisi C
    J Mol Biol; 1997 Apr; 267(5):1258-67. PubMed ID: 9150410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide sequences binding to MHC class I proteins.
    Smith MH; Lam KS; Hersh EM; Lebl M; Grimes WJ
    Mol Immunol; 1994 Dec; 31(18):1431-7. PubMed ID: 7823969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural prediction of peptides binding to MHC class I molecules.
    Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
    Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential down-modulation of HLA-G and HLA-A2 or -A3 cell surface expression following human cytomegalovirus infection.
    Pizzato N; Garmy-Susini B; Le Bouteiller P; Lenfant F
    J Reprod Immunol; 2004 Jun; 62(1-2):3-15. PubMed ID: 15288176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selecting informative data for developing peptide-MHC binding predictors using a query by committee approach.
    Christensen JK; Lamberth K; Nielsen M; Lundegaard C; Worning P; Lauemøller SL; Buus S; Brunak S; Lund O
    Neural Comput; 2003 Dec; 15(12):2931-42. PubMed ID: 14629874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Support vector machine-based prediction of MHC-binding peptides.
    Dönnes P
    Methods Mol Biol; 2007; 409():273-82. PubMed ID: 18450007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules.
    Sidney J; Southwood S; del Guercio MF; Grey HM; Chesnut RW; Kubo RT; Sette A
    J Immunol; 1996 Oct; 157(8):3480-90. PubMed ID: 8871647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations.
    Chen Y; Sidney J; Southwood S; Cox AL; Sakaguchi K; Henderson RA; Appella E; Hunt DF; Sette A; Engelhard VH
    J Immunol; 1994 Mar; 152(6):2874-81. PubMed ID: 8144888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.
    Parker KC; Bednarek MA; Coligan JE
    J Immunol; 1994 Jan; 152(1):163-75. PubMed ID: 8254189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential human respiratory syncytial virus and metapneumovirus T cell epitopes using computational prediction and MHC binding assays.
    Rock MT; McKinney BA; Yoder SM; Prudom CE; Wright DW; Crowe JE
    J Immunol Methods; 2011 Nov; 374(1-2):13-7. PubMed ID: 21854782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSAR method for prediction of protein-peptide binding affinity: application to MHC class I molecule HLA-A*0201.
    Zhao C; Zhang H; Luan F; Zhang R; Liu M; Hu Z; Fan B
    J Mol Graph Model; 2007 Jul; 26(1):246-54. PubMed ID: 17275373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting peptides that bind to MHC molecules using supervised learning of hidden Markov models.
    Mamitsuka H
    Proteins; 1998 Dec; 33(4):460-74. PubMed ID: 9849933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving MHC binding peptide prediction by incorporating binding data of auxiliary MHC molecules.
    Zhu S; Udaka K; Sidney J; Sette A; Aoki-Kinoshita KF; Mamitsuka H
    Bioinformatics; 2006 Jul; 22(13):1648-55. PubMed ID: 16613909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.